| Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders |
The
following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders
(in thousands, except share and per share data):
Schedule
of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders
| | |
| | | |
| | | |
| | | |
| | |
| | |
Three
Months Ended | | |
Six Months
Ended | |
| | |
June
30, | | |
June
30, | |
| | |
2023 | | |
2022 | | |
2023 | | |
2022 | |
| Net income (loss) | |
$ | (9,837 | ) | |
$ | (850 | ) | |
$ | (17,315 | ) | |
$ | 4,711 | |
| | |
| | | |
| | | |
| | | |
| | |
| Shares: | |
| | | |
| | | |
| | | |
| | |
| Basic weighted average common shares outstanding | |
| 1,360,739 | | |
| 941,175 | | |
| 1,359,894 | | |
| 898,444 | |
| Add: Effect of dilutive securities | |
| | | |
| | | |
| | | |
| | |
| Stock options and restricted stock units | |
| - | | |
| - | | |
| - | | |
| 3,765 | |
| Diluted weighted average common shares outstanding | |
| 1,360,739 | | |
| 941,175 | | |
| 1,359,894 | | |
| 902,209 | |
| | |
| | | |
| | | |
| | | |
| | |
| Net earnings (loss) per share: | |
| | | |
| | | |
| | | |
| | |
| Basic | |
$ | (7.23 | ) | |
$ | (0.90 | ) | |
$ | (12.73 | ) | |
$ | 5.24 | |
| Diluted | |
$ | (7.23 | ) | |
$ | (0.90 | ) | |
$ | (12.73 | ) | |
$ | 5.22 | |
|
Basic
and diluted net loss per share attributable to common stockholders is calculated as follows (in thousands, except share and per share
amounts):
Schedule
of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders
| | |
| | | |
| | |
| | |
For years
ended December 31, | |
| | |
2022 | | |
2021 | |
| Net loss | |
$ | (640 | ) | |
$ | (37,713 | ) |
| Weighted average common shares outstanding, basic and diluted | |
| 1,056,988 | | |
| 440,412 | |
| Net loss per share, basic and diluted | |
$ | (0.61 | ) | |
$ | (85.63 | ) |
|
| Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share |
The
following table sets forth the weighted average of securities that were anti-dilutive for diluted EPS for the periods presented but which
could potentially dilute EPS in the future:
Schedule
of Anti-dilutive Securities Excluded From Computation of Earnings Per Share
| June 30, | |
2023 | | |
2022 | |
| Common stock warrants | |
| 1,877,630 | | |
| 1,806,202 | |
| Common stock options and RSUs | |
| 106,034 | | |
| 42,428 | |
| Unit Purchase Options | |
| 20,182 | | |
| 20,182 | |
| Anti-dilutive
securities excluded from computation of earnings per share | |
| 20,182 | | |
| 20,182 | |
|
The
following table sets forth securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute
EPS in the future:
Schedule
of Anti-dilutive Securities Excluded From Computation of Earnings Per Share
| | |
| | | |
| | |
| December 31, | |
2022 | | |
2021 | |
| Common stock warrants | |
| 459,856 | | |
| 217,477 | |
| Common stock options and RSUs | |
| 104,127 | | |
| 39,241 | |
| Unit Purchase Options | |
| 20,182 | | |
| 20,182 | |
| Anti-dilutive securities excluded from computation of earnings
per share | |
| 403,628 | | |
| 403,628 | |
|